Number of Subjects with Adverse Events Up to 70 days following the last scheduled administration of Humira Injection, an expected average of 3 months [clinicaltrials_resource:0e8561526b7b7e637c59c5a34d89d53b]
Active Joint Count will be assessed and collected by participated investigators in routine medical practice
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of Subjects with Adverse Events Up to 70 days following the last scheduled administration of Humira Injection, an expected average of 3 months [clinicaltrials_resource:0e8561526b7b7e637c59c5a34d89d53b]
Active Joint Count will be assessed and collected by participated investigators in routine medical practice
Bio2RDF identifier
0e8561526b7b7e637c59c5a34d89d53b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0e8561526b7b7e637c59c5a34d89d53b
measure [clinicaltrials_vocabulary:measure]
Number of Subjects with Adverse Events
time frame [clinicaltrials_vocabulary:time-frame]
Up to 70 days following the la ...... n expected average of 3 months
description
Active Joint Count will be ass ...... rs in routine medical practice
identifier
clinicaltrials_resource:0e8561526b7b7e637c59c5a34d89d53b
title
Number of Subjects with Advers ...... n expected average of 3 months
@en
type
label
Number of Subjects with Advers ...... 561526b7b7e637c59c5a34d89d53b]
@en